These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 24553870)
1. Induced pluripotent stem cells and neurological disease models. Cai S; Chan YS; Shum DK Sheng Li Xue Bao; 2014 Feb; 66(1):55-66. PubMed ID: 24553870 [TBL] [Abstract][Full Text] [Related]
2. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery. Corti S; Faravelli I; Cardano M; Conti L Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144 [TBL] [Abstract][Full Text] [Related]
3. Modeling human neurological disorders with induced pluripotent stem cells. Imaizumi Y; Okano H J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589 [TBL] [Abstract][Full Text] [Related]
4. Modeling neurological diseases using iPSC-derived neural cells : iPSC modeling of neurological diseases. Li L; Chao J; Shi Y Cell Tissue Res; 2018 Jan; 371(1):143-151. PubMed ID: 29079884 [TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells for modeling of pediatric neurological disorders. Jang J; Quan Z; Yum YJ; Song HS; Paek S; Kang HC Biotechnol J; 2014 Jul; 9(7):871-81. PubMed ID: 24838856 [TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cells: a new revolution for clinical neurology? Mattis VB; Svendsen CN Lancet Neurol; 2011 Apr; 10(4):383-94. PubMed ID: 21435601 [TBL] [Abstract][Full Text] [Related]
7. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases. Zhang X; Hu D; Shang Y; Qi X Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165431. PubMed ID: 30898538 [TBL] [Abstract][Full Text] [Related]
8. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y; Deng W Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934 [TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery. Rowntree RK; McNeish JD Regen Med; 2010 Jul; 5(4):557-68. PubMed ID: 20632859 [TBL] [Abstract][Full Text] [Related]
10. Neural Stem Cells Derived from Human-Induced Pluripotent Stem Cells and Their Use in Models of CNS Injury. Jendelova P; Sykova E; Erceg S Results Probl Cell Differ; 2018; 66():89-102. PubMed ID: 30209655 [TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cells in the study of neurological diseases. Saporta MA; Grskovic M; Dimos JT Stem Cell Res Ther; 2011 Sep; 2(5):37. PubMed ID: 21936964 [TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening. Song M; Paul S; Lim H; Dayem AA; Cho SG Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779 [TBL] [Abstract][Full Text] [Related]